Mar­ket­ingRx roundup: Ab­bott teams with Weight­Watch­ers for glu­cose mon­i­tor­ing; Ha­le­on’s Advil starts ‘pain eq­ui­ty’ ef­fort

Ab­bott is part­ner­ing with Weight­Watch­ers (WW) to help di­eters with type 2 di­a­betes bet­ter track their glu­cose lev­els. WW mem­bers can now ac­cess the da­ta from their Freestyle Li­bre 2 con­tin­u­ous glu­cose mon­i­tor (CGM) in­side their di­a­betes di­etary plan app.

Po­si­tion­ing the matchup as “the #1 doc­tor-rec­om­mend­ed weight-loss plan meets the #1 pre­scribed CGM,” the part­ners aim to make liv­ing and eat­ing with di­a­betes more sim­ple. The di­a­betes-tai­lored plan from WW and the Ab­bott CGM blood sug­ar mon­i­tor aim to com­bine weight loss and low­er­ing A1C goals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER